[EN] SUBSTITUTED PYRIDINE DERIVATIVES USEFUL AS GPR131 AGONISTS<br/>[FR] DÉRIVÉS PYRIDINES SUBSTITUÉES UTILES EN TANT QU'AGONISTES DE GPR131
申请人:MERCK SHARP & DOHME
公开号:WO2013062887A1
公开(公告)日:2013-05-02
Compounds of structural Formula (I) are inhibitors of GPR131. The compounds of the present invention are useful for the prevention and treatment of conditions related to the activity of GPR131 such as abnormal metabolism, including obesity; diabetes; metabolic syndrome; obesity related disorders; and diabetes related disorders.
结构式(I)的化合物是GPR131的抑制剂。本发明的化合物对预防和治疗与GPR131活性相关的疾病非常有用,如异常代谢,包括肥胖、糖尿病、代谢综合征、与肥胖相关的疾病以及与糖尿病相关的疾病。